When evaluating a client's use of a metered-dose inhaler (MDI), the nurse notes that the client is unable to coordinate the activation of the inhaler with her breathing. What intervention is most appropriate at this time?

What is the nurse’s priority action if extravasation of an antineoplastic drug occurs during intravenous (IV) administration?

A client who has received some traumatic news is panicking and asks for some medication to help settle down. The nurse anticipates giving which drug that is most appropriate for this situation?

A nurse is preparing to administer clindamycin palmitate 225 mg PO every 8 hr to a client. The amount available is clindamycin palmitate oral suspension 75 m/5mL. How many ml- should the nurse administer? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)

A nurse is providing teaching to a client who has seizures and a new prescription for phenytoin. Which of the following information should the nurse provide?

A client with a tracheostomy has difficulty removing excessive, thick mucus from the respiratory tract. The nurse expects that which drug will be ordered to aid in the removal of mucus?

The nurse is developing a care plan for a client who will be self-administering a metered-dose inhaler. Which statement reflects a measurable outcome?

During therapy with the hematopoietic drug epoetin alfa, the nurse instructs the client about adverse effects that may occur, such as:

A nurse is caring for a client who has a pulmonary embolism and has a new prescription for enoxaparin 1.5mg/kg/dose subcutaneous every 12 hr. The client weighs 245 lbs. How many mg should the nurse administer per dose? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)

A client is in the urgent care center after experiencing a black widow spider bite. The nurse prepares to give which product to treat this injury?

A client with a history of chronic obstructive pulmonary disease (CORD) and type 2 diabetes has been treated for pneumonia for the past week. The client has been receiving intravenous corticosteroids as well as antibiotics as part of his therapy. At this time, the pneumonia has resolved, but when monitoring the blood glucose levels, the nurse notices that the level is still elevated.

What is the best explanation for this elevation?